Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects

Abstract Amyloid‐β (Aβ) is a pivotal biomarker in Alzheimer's disease (AD), attracting considerable attention from numerous researchers. There is uncertainty regarding whether clearing Aβ is beneficial or harmful to cognitive function. This question has been a central topic of research, especia...

Full description

Bibliographic Details

Published in:	Ibrain
Main Authors:	Yifan Yu, Shilong Yu, Giuseppe Battaglia, Xiaohe Tian
Format:	Article
Language:	English
Published:	Wiley-VCH 2024-09-01
Subjects:	Aβ Alzheimer's disease anti‐Aβ drugs multivalency nanodrugs
Online Access:	https://doi.org/10.1002/ibra.12155